Extramedullary (EM) manifestations of acute leukemia include a wide variety of clinically
significant phenomena that often pose therapeutic dilemmas. Myeloid sarcoma (MS) and …

Abstract The World Health Organization classification and definition of “myeloid sarcoma” is
imprecise and misleading. A more accurate term is “extramedullary acute myeloid leukemia …

Purpose Extramedullary disease (EMD) at diagnosis in patients with acute myeloid leukemia
(AML) has been recognized for decades. Reported herein are results from a large study of …

Myeloid sarcoma (MS), also termed extramedullary acute myeloid leukemia, extramedullary
myeloid tumor, and granulocytic sarcoma or chloroma, is a rare manifestation that is …

Extramedullary myeloid sarcoma (MS, also known as granulocytic sarcoma, myeloblastoma
or chloroma) is a rare form (o1%) of extramedullary acute myeloid leukemia (AML) …

Background Extramedullary manifestations (EM) are rare in acute myeloid leukemia (AML)
and their impact on clinical outcomes is controversially discussed. Methods We …

PURPOSE To discuss the predisposing risk factor for all forms of extramedullary leukemia
(EML) and to review the clinical features, prognostic significance, and treatment strategies …

Background Extramedullary infiltration (EMI) is an occasional clinical symptom in childhood
acute myelogenous leukemia (AML), but there is considerable controversy regarding the …

We evaluated the frequency and prognostic significance of extramedullary infiltrates (EMI) at
presentation of acute myeloid leukemia (AML) in adult patients. Of 331 cases with de novo …

More than one quarter of a million adults throughout the world are diagnosed annually with
acute myeloid leukemia (AML). Despite considerable progress during the past 3 decades in …